Marex Group Ltd
Institutional investor · Portfolio as of Q2 2025
Top Holdings642 positions
MicroStrategy Inc | 3.3M | $1.3B | 11.6% | — | — | — | New — |
MicroStrategy Inc | 1.9M | $759.9M | 6.6% | $239.69 | +68.65% | 6 qtrssince 2024-Q1 | Increased 69 |
Priceline Group Inc/The | 89,700 | $519.3M | 4.5% | — | — | — | New — |
Mastercard Inc | 777,714 | $437M | 3.8% | $552.61 | +0.92% | 5 qtrssince 2024-Q2 | Increased 92 |
Mastercard Inc | 772,000 | $433.8M | 3.8% | — | — | — | New — |
Priceline Group Inc/The | 64,811 | $375.2M | 3.3% | $195.05 | +17.44% | 7 qtrssince 2023-Q4 | Increased 92 |
Tesla Inc | 1.1M | $357.2M | 3.1% | — | — | — | New — |
Tesla Inc | 770,000 | $244.6M | 2.1% | — | — | — | New — |
Eli Lilly & Co | 284,407 | $221.7M | 1.9% | $715.89 | +7.97% | 9 qtrssince 2023-Q2 | Increased 64 |
Eli Lilly & Co | 282,500 | $220.2M | 1.9% | — | — | — | New — |
Berkshire Hathaway Inc | 400,000 | $194.3M | 1.7% | — | — | — | New — |
Tesla Inc | 545,241 | $173.2M | 1.5% | $390.04 | -18.56% | 7 qtrssince 2023-Q4 | Decreased 0 |
Intuit Inc | 198,139 | $156.1M | 1.4% | $635.24 | +22.45% | 6 qtrssince 2024-Q1 | Increased 54 |
Intuit Inc | 195,000 | $153.6M | 1.3% | — | — | — | New — |
Priceline Group Inc/The | 25,000 | $144.7M | 1.3% | — | — | — | New — |
Robinhood Markets Inc | 1.5M | $133.7M | 1.2% | $57.64 | +44.05% | 7 qtrssince 2023-Q4 | Increased 70 |
NVIDIA Corp | 824,371 | $130.2M | 1.1% | $83.27 | +89.27% | 7 qtrssince 2023-Q4 | Decreased 0 |
Netflix Inc | 90,000 | $120.5M | 1.0% | — | — | — | New — |
UnitedHealth Group Inc | 360,000 | $112.3M | 1.0% | — | — | — | New — |
Netflix Inc | 80,000 | $107.1M | 0.9% | — | — | — | New — |
Marex Group Ltd manages $11.5B across 642 positions as of Q2 2025. Top holdings: MSTR puts (11.6%), MSTR (6.6%), BKNG puts (4.5%). Fund DNA: Momentum Trader. HoldingsIntel Score: 1/5.0.
Active quarter - 174 new positions, 340 exits, 137 increased. Top move: MA (INCREASED, conviction 92). Portfolio: $11.5B across 642 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer
Verify source filings on SEC EDGAR